Sanofi pasteur is the vaccine division of sanofi-aventis Group. It is the largest company in the world devoted entirely to vaccines.

History

In 2004, Aventis merged with and into Sanofi. The new sanofi-aventis Group became the world's 3rd largest pharmaceutical company. Aventis Pasteur, the vaccine division of sanofi-aventis Group, changed its name to sanofi pasteur.

Key Dates

• 1897, Marcel Mérieux creates the Mérieux Biological Institute in Lyon. Richard Slee creates the Pocono Biological Laboratories, in Swiftwater, Pennsylvania in the US
• 1914, John FitzGerald creates Connaught Laboratories, part of the University of Toronto.
• 1968, Rhône-Poulenc acquires 51% of the capital of the Institut Mérieux.
• 1974, Pasteur Institute creates Pasteur Production, a subsidiary specializing in manufacturing vaccines
• 1978, Connaught Laboratories in Canada acquires the vaccine manufacturing facility (Merrell-National Laboratories) at Swiftwater, Pennsylvania, US.
• 1985, Pasteur Production, the vaccines branch of the Institut Pasteur, is acquired by the Mérieux Institute, and Pasteur Vaccins is created
• 1989, The Mérieux Institute acquires the Connaught Laboratories in Canada and its subsidiaries and becomes a world leader in human biology
• 1990, Creation of Pasteur Mérieux Serums & Vaccins
• 1994, Pasteur Mérieux Sérums & Vaccins becomes a wholly owned subsidiary of Rhône-Poulenc.
• 1996, Pasteur Mérieux Connaught is the new name of Pasteur Mérieux Serums et Vaccins
• 1999, Rhône-Poulenc and Hoechst unite their Life Sciences activities in a single company, which takes on the name Aventis. Within this group, Pasteur Mérieux Connaught changes its name to Aventis Pasteur.
• 2004, merger of Aventis with and into Sanofi. The new sanofi-aventis Group becomes the world's 3rd largest pharmaceutical company, behind Pfizer and GlaxoSmithKline. Aventis Pasteur, the vaccine division of the sanofi-aventis Group, changes its name to sanofi pasteur.

Key facts & figures in 2006

• Sanofi pasteur - 2006 net sales: € 2,533 millions (+22.7% over 2005)
• Staff: nearly 10,000 employees
• More than a billion doses of vaccines provided to immunize more than 500 million people in the world
• A wide range of vaccines protecting against 20 bacterial and viral diseases
• A global presence
• More than US$ 1 million invested every day in R&D
• Headquarters: Lyon, France
• US Manufacturing Site: Swiftwater, PA

Vaccines

• TheraCys - bladder cancer
• ADACEL (Tdap) - diphtheria, tetanus and pertussis
• DAPTACEL (DTaP) - diphtheria, tetanus and pertussis
• Diphtheria and Tetanus Toxoids Adsorbed USP, diphtheria, tetanus and pertussis
• Tetanus Toxoid Adsorbed - diphtheria, tetanus and pertussis
• TriHIBit (DTaP/Hib Booster Use) - diphtheria, tetanus and pertussis and haemophilus influenzae type b
• Tripedia (DTaP vaccine) - diphtheria, tetanus, pertussis
• ActHIB - haemophilus influenzae type b
• Fluzone, Influenza Virus Vaccine - influenza
• Fluzone, Influenza Virus Vaccine, No Preservative - influenza
• Fluzone, Influenza Virus Vaccine, No Preservative: Ped Dose - influenza
• Menactra - meningococcal
• Menomune-A/C/Y/W-135 - meningococcal
• IPOL - Polio
• Imogam Rabies-HT - rabies immune globulin
• IMOVAX RABIES - rabies
• DECAVAC - tetanus and diphtheria
• Tetanus Toxoid Adsorbed - tetanus
• Tetanus Toxoid For Booster Use Only - tetanus
• JE-VAX - Japanese encephalitis virus
• Typhim Vi - typhoid fever
• YF-VAX - yellow fever
• Tubersol - tuberculosis

References